Вторник, 12 Декабря 2017
Latest news
Main » GlaxoSmithKline plc (ADR) (GSK) EPS Estimated At $0.83

GlaxoSmithKline plc (ADR) (GSK) EPS Estimated At $0.83

12 Октября 2017

The firm's market cap is GBX 74.15 billion. About 745,310 shares traded. GlaxoSmithKline plc (ADR) (NYSE:GSK) has risen 4.26% since October 11, 2016 and is uptrending. It has underperformed by 9.03% the S&P500. The shares were acquired at an average cost of GBX 2,072 ($26.75) per share, with a total value of £1,160.32 ($1,497.77).

GlaxoSmithKline plc (LON:GSK) traded up 0.58% on Friday, hitting GBX 1647.50. It has outperformed by 64.66% the S&P500.

The consensus recommendation, according to Zacks Investment research, is 2.

Investors sentiment decreased to 1.22 in Q2 2017. The company's 50 day moving average price is GBX 1,500.18 and its 200-day moving average price is GBX 1,586.54. A rating of 4 or 5 would represent a Sell recommendation. 15 funds opened positions while 24 raised stakes. The stock of Unilever NV (ADR) (NYSE:UN) has "Underperform" rating given on Thursday, August 10 by RBC Capital Markets. The company has its outstanding shares of 2.44B. There has been an observed change of 0.00% in the ownership of the shares in the past six months. Goldman Sachs reported 1,841 shares. Looking out over the past year, company shares have been recorded -12.66% off the 52 week high and 12.99% away from the low over the same period. UBS AG's target price would indicate a potential upside of 2.18% from the stock's previous close. More interesting news about Texas Pacific Land Trust (NYSE:TPL) were released by: Seekingalpha.com and their article: "Texas Pacific Land Trust Is Slowly Liquidating Itself" published on October 16, 2016 as well as Businessinsider.com's news article titled: "One Of The Hottest Stocks On The NYSE Is A Company Most Of Us Have Never Heard ..." with publication date: August 07, 2014. It also upped Schlumberger Ltd (NYSE:SLB) stake by 60 shares and now owns 14,516 shares.

Choate Investment Advisors increased Travelers Companies Inc (NYSE:TRV) stake by 280 shares to 6,588 valued at $833.58M in 2017Q2.

Читайте также: Royal Mail wins court injunction to prevent strike

Stock market analysts and brokers have recently amended their target prices on shares of GlaxoSmithKline PLC (NYSE:GSK). The expected GSK's profit could reach $1.99B giving the stock 12.27 P/E in the case that $0.83 earnings per share is reported. Therefore 47% are positive. Berenberg Bank set a GBX 1,850 ($23.88) price target on shares of GlaxoSmithKline plc and gave the company a neutral rating in a research report on Monday, January 23rd.

12/19/2016 - GlaxoSmithKline PLC had its "buy" rating reiterated by analysts at Jefferies.

GlaxoSmithKline PLC had its "buy" rating reiterated by analysts at Argus. Scotia Capital Inc.'s holdings in GlaxoSmithKline PLC were worth $3,200,000 as of its most recent SEC filing. BNP Paribas upgraded GlaxoSmithKline plc (ADR) (NYSE:GSK) on Tuesday, September 15 to "Neutral" rating. As per Thursday, September 3, the company rating was maintained by Bernstein.

10/25/2016 - GlaxoSmithKline PLC had its "neutral" rating reiterated by analysts at JP Morgan. The stock of GlaxoSmithKline plc (ADR) (NYSE:GSK) has "Neutral" rating given on Wednesday, April 5 by BNP Paribas. The firm has "Buy" rating by Berenberg given on Friday, September 25. JP Morgan maintained the stock with "Neutral" rating in Wednesday, May 31 report. The correct version of this news story can be accessed at https://www.truebluetribune.com/2017/10/12/scotia-capital-inc-has-3-20-million-holdings-in-glaxosmithkline-plc-gsk.html.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2017 Copyright.
Автоматизированное извлечение информации сайта запрещено.

Код для вставки в блог